Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

2. Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer

Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer - Health Quality Ontario (HQO) Let's make our health system healthier Open Menu Quick Links Search Search A A A Evidence to Improve Care Share: Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening (...) in Women at Less Than High Risk for Breast Cancer Ontario Health Technology Advisory Committee Recommendation The Ontario Health Technology Advisory Committee recommends against publicly funding screening breast magnetic resonance imaging (MRI) as an adjunct to screening mammography for women who are at less than high risk for breast cancer and who have no personal history of breast cancer Breast cancer is the most common cancer among Canadian women. The most common form of screening for breast cancer

2017 Health Quality Ontario

3. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. (PubMed)

Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. Breast cancer is the most common malignant disease diagnosed in women worldwide. Screening with mammography has the ability to detect breast cancer at an early stage. The diagnostic accuracy of mammography screening largely depends on the radiographic density of the imaged breasts. In radiographically dense breasts, non-calcified breast cancers are more likely (...) to be missed than in fatty breasts. As a consequence, some cancers are not detected by mammography screening. Supporters of adjunct ultrasonography to the screening regimen for breast cancer argue that it might be a safe and inexpensive approach to reduce the false negative rates of the screening process. Critics, however, are concerned that performing supplemental ultrasonography on women at average risk will also increase the rate of false positive findings and can lead to unnecessary biopsies

Full Text available with Trip Pro

2013 Cochrane

4. Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women atless than high risk for breast cancer: a health technology assessment

Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women atless than high risk for breast cancer: a health technology assessment Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment (...) Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario health technology assessment series

2017 Health Technology Assessment (HTA) Database.

5. Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation

Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation Health Quality Ontario Record (...) Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation. Toronto: Health Quality Ontario (HQO). 2016 Authors' conclusions The Ontario Health Technology Advisory Committee (OHTAC

2017 Health Technology Assessment (HTA) Database.

6. Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit

Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of clinical breast examination, before conventional mammography, for women at a high risk of breast cancer, given their family history. The authors concluded that clinical

Full Text available with Trip Pro

2013 NHS Economic Evaluation Database.

7. Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation

Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) Health Quality Ontario. Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation. Toronto: Health Quality Ontario (HQO). 2016 Authors' conclusions The Ontario Health Technology Advisory Committee recommends publicly funding screening breast ultrasound as an adjunct to screening mammography for high-risk women in whom magnetic resonance imaging (MRI) is contraindicated. The Ontario Health Technology Advisory Committee recommends against publicly funding screening

2016 Health Technology Assessment (HTA) Database.

8. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with TOMMY trial: A comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry (...) Manchester, Manchester, UK 8 Department of Radiology, St Bartholomew’s Hospital, London, UK 9 National Co-ordinating Centre for Physics of Mammography, Royal Surrey County Hospital, Guildford, UK 10 Department of Imaging Science and Biomedical Engineering, University of Manchester, Manchester, UK 11 East Anglian Regional Radiation Protection Service, Cambridge University Hospitals, Cambridge, UK 12 Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK * Corresponding

2015 NIHR HTA programme

9. (1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007).

(1) ACS guidelines for breast cancer screening: update 2003. (2) American Cancer Society Guideline for breast screening with MRI as an adjunct to mammography (2007). Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient

2008 American Cancer Society

10. Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment

Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Health Quality Ontario. Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario health technology assessment series; 16(15). 2016 Authors' conclusions We found no evidence that evaluated the comparative effectiveness or diagnostic accuracy of screening breast ultrasound as an adjunct to mammography among average-risk women aged 50 years and over. In women at high risk of developing

2016 Health Technology Assessment (HTA) Database.

11. Tomosynthesis (3D Mammography) for Breast Cancer Screening

Tomosynthesis (3D Mammography) for Breast Cancer Screening Tomosynthesis (3D Mammography) for Breast Cancer Screening | CADTH.ca Find the information you need Tomosynthesis (3D Mammography) for Breast Cancer Screening Tomosynthesis (3D Mammography) for Breast Cancer Screening Published on: May 13, 2015 Project Number: EH0026 Product Line: Issue: 135 Result type: Report Summary Digital breast tomosynthesis (DBT) is a novel imaging technology that captures three-dimensional (3D) images (...) detection. Implementation issues include the significant cost to purchase the technology, training requirements for radiologists and technologists, increased radiologist interpretation time, and greater data storage requirements. The Technology Traditional two-dimensional (2D) mammography captures two static images of the breast. One particular shortcoming of 2D technology is the overlapping of breast images that can decrease accuracy of interpretation. With digital breast tomosynthesis (DBT), an X-ray

2015 CADTH - Issues in Emerging Health Technologies

12. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost

Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost (...) with ultrasound (US) in self-referring women with dense breasts and a negative report on mammography. US detected early-stage cancers in women with mammography-negative dense breasts, especially in women younger than 50 years, but with substantial financial implications. Overall, the reporting of the clinical data was satisfactory. However, there was little information on the cost analysis and the issue of uncertainty was not addressed, so caution is required when interpreting the authors’ conclusions. Type

2008 NHS Economic Evaluation Database.

13. Breast cancer screening and mammography: inform women

Breast cancer screening and mammography: inform women Prescrire IN ENGLISH - Spotlight ''Breast cancer screening and mammography: inform women '', 1 July 2015 {1} {1} {1} | | > > > Breast cancer screening and mammography: inform women Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Breast cancer screening and mammography: inform women Information (...) must be shared with women to help them decide whether or not to take part in breast cancer screening. In a series of articles published over the past year, Prescrire updated its analysis of the harm-benefit balance of breast cancer screening by mammography. In France, it is estimated that, overall, for every 1000 woman aged 50, around 72 women are diagnosed with breast cancer over a period of 20 years. In the 10 years following this diagnosis, around 13 of these women die from breast cancer, and 4

2015 Prescrire

14. Screening mammography program: physician protocol for screening mammograms

Screening mammography program: physician protocol for screening mammograms Screening Mammography Program Physician Protocol for Screening Mammograms risk policy rationale Average risk Ages 40-49 Health care providers are encouraged to discuss the benefits and limitations of screening mammography with asymptomatic women in this age group. If screening mammography is chosen, it is available every two years. Patients will be recalled every two years. A health care provider’s referral (...) in women ages 50 and older who have no risk factors other than being an aging female. Average risk Ages 75+ Health care providers are encouraged to discuss the benefits and limitations of screening mammography with asymptomatic women in this age group. Health care providers should discuss stopping screening when there are comorbidities associated with a limited life expectancy or physical limitations for mammography that prevent proper positioning. If screening mammography is chosen, it is available

2014 CPG Infobase

15. Tomosynthesis (3D Mammography) for Breast Cancer Screening

Tomosynthesis (3D Mammography) for Breast Cancer Screening 1 Issue 135 ? May 2015 Issues in Emerging Health Technologies Summary ? Digital breast tomosynthesis (DBT) is a novel imaging technology that captures three- dimensional (3D) images of the breast. ? DBT can be used for screening or diagnosis. ? Seven recent, large screening studies that each enrolled more than 10,000 women showed that DBT can reduce the need to recall women for further testing compared with current two- dimensional (2D (...) Traditional two-dimensional (2D) mammography captures two static images of the breast. One particular shortcoming of 2D technology is the overlapping of breast images that can decrease accuracy of interpretation. With digital breast tomosynthesis (DBT), an X-ray beam sweeps in an arc of 15 to 50 degrees (depending on the manufacturer) across the breast, and an electronic detector digitally captures between nine and 25 X-ray projection images. 1-6 These images are generally captured in two views

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

16. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis

Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

17. Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer

Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer Health Technology Assessment - Health Quality Ontario (HQO) Let's make our health system healthier Open Menu Quick Links Search Search A A A Evidence to Improve Care Share: Health Technology Assessment To continuously improve the quality of health care in Ontario, we use established scientific methods to analyze evidence and develop assessments of new

2016 Health Quality Ontario

18. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) cancer risk factors between screened and unscreened women and what estimates are used when making these adjustments; the duration for which women are followed after screening cessation; the estimates used for lead-time effects (i.e., the time diagnosis was brought forward through screening); whether account is taken of non-diagnostic mammography outside the screening program and how this is done; death rates from other diseases and hence variations in life expectancy at time of screening; screening

2014 Cancer Australia

19. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening

Ultrasound as an Adjunct to Mammography for Breast Cancer Screening Health Quality Ontario The provincial advisor on the quality of health care in Ontario Let’s make our health system healthier Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: OHTAC Recommendation ONTARIO HEALTH TECHNOLOGY ADVISORY COMMITTEE RECOMMENDATIONS ? The Ontario Health Technology Advisory Committee recommends publicly funding screening breast ultrasound as an adjunct to screening mammography for high (...) -risk women in whom magnetic resonance imaging (MRI) is contraindicated. ? The Ontario Health Technology Advisory Committee recommends against publicly funding screening breast ultrasound as an adjunct to screening mammography in women at average risk for breast cancer. RATIONALE FOR THE RECOMMENDATION DECISION Given the absence of evidence demonstrating benefit, 1 there was consensus among members of the Ontario Health Technology Advisory Committee (OHTAC) that adjunct screening breast ultrasound

2016 Health Quality Ontario

20. Can adding contrast-enhanced digital mammography (CEDM) as an adjunct to diagnostic mammography/US help decrease biopsy rates in women with suspicious (BIRADS 4) breast lesions? (PubMed)

Can adding contrast-enhanced digital mammography (CEDM) as an adjunct to diagnostic mammography/US help decrease biopsy rates in women with suspicious (BIRADS 4) breast lesions?

2015 Journal of Clinical Oncology